Financial comparisons Protagonist Therapeutics, Inc.
Equities
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.79 USD | +1.07% |
|
+0.05% | -2.92% |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 434M | 63.34% | 58.2% | 54.39% | 49.91% | -0.38x | |
| 7.25B | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | |
| 15.4B | 8.91% | 20.12% | 33.53% | 5.12% | 3.33x | |
| 3.81B | -16.92% | -14.91% | -18.77% | -11% | 4.06x | |
| 2.41B | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | |
| 2.11B | 19.17% | 21.38% | 58.42% | 21.52% | -1.39x | |
| 7.2B | 5.84% | 14.63% | 7.8% | 3.73% | 1.93x | |
| 8.28B | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | |
| 376M | -103.97% | -76.66% | - | -37.71% | -1.14x | |
| 705M | -64.4% | -67.38% | -93.12% | -15.15% | 2.26x | |
| 693M | -107.63% | -20.47% | - | -25.37% | 0.13x | |
| 1.98B | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | |
| 4.05B | 0.25% | 19.9% | 15.1% | 6.78% | 2.05x | |
| 1.22B | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | |
| Average | 3.99B | -11% | 4.71% | 8.97% | 2.16% | 1.15x | |
| Weighted average by Cap. | 5.55B | -7.24% | 4.96% | 7.4% | 0.27% | 1.68x |
- Stock Market
- Equities
- PTGX Stock
- Sector Protagonist Therapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition